Related Experiment Video

Updated: Jun 6, 2025

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.1K

B7-H4: A potential therapeutic target in adenoid cystic carcinoma

Luana Guimaraes de Sousa, Renata Ferrarotto

    Oncotarget
    |November 22, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    adenoid cystic carcinomaantibody drug conjugateb7-h4rare cancersalivary gland cancer

    More Related Videos

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    11.4K
    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
    06:11

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

    Published on: April 20, 2018

    9.7K

    Related Experiment Videos

    Last Updated: Jun 6, 2025

    Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
    10:11

    Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

    Published on: January 3, 2013

    23.1K
    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    11.4K
    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
    06:11

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

    Published on: April 20, 2018

    9.7K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.5K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.

    European journal of cancer (Oxford, England : 1990)·2026

    Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study.

    Pain medicine (Malden, Mass.)·2026

    Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer.

    JAMA network open·2026

    Prognostic Impact of MYC/TP63 Molecular Subtypes in Adenoid Cystic Carcinoma: A Meta-Analysis.

    Cancers·2026

    Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Outcomes of different treatment patterns for adenoid cystic carcinoma of the anterior craniofacial area: A multi-institutional study on 578 patients.

    European journal of cancer (Oxford, England : 1990)·2026

    Are both COVID-19 and COVID-19 vaccines associated with cancer?

    Oncotarget·2026

    Re-expression of MHC-I to treat CNS cancers.

    Oncotarget·2026

    Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

    European journal of nuclear medicine and molecular imaging·2026

    Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

    Gut·2026

    Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

    Journal of Crohn's & colitis·2026

    Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.

    Biochimica et biophysica acta. Reviews on cancer·2026

    Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

    Biochimica et biophysica acta. Reviews on cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us